Recently, Proteus Digital Health, a digital pharmaceutical company headquartered in California, USA, received a $50 million H-round financing, which investors have not disclosed. The company's existing investors include Medtronic, Itochu, St. Jude Medical, and Kaiser Permanente Ventures. After the round of financing, the company received a total of $350 million in financing.
Smart Pills detect drug metabolism in humans and have been approved by the FDA
Founded in 2001, Proteus Digital Health develops digital medical products that collect a variety of behavioral, physiological, therapeutic and other human indicators, including continuous medication, heart rate, sleep patterns, physical activity, stress levels, etc. Health management tools. The company's digital medical platform is called Proteus Discover, a medical management system that consists of three parts:
Swallowable smart chip pill with sensor
Smart patch
Mobile device APP
Smart pills are no different from ordinary pills in appearance, but they contain a sand-sized sensor that monitors how the drug is metabolized and works in the body. After the patient takes the pill, the pill reaches the stomach of the human body, and the electrode in the sensor in the pill receives electricity from the stomach acid, and the sensor transmits a signal to the outside. With smart patches attached to the skin, the sensor measures various physiological parameters such as heart rate, breathing, body angle, activity, and sleep patterns, which are sent to the associated mobile app. And this smart patch has been approved by the FDA in 2010, and the smart chip pill was also approved by the FDA in July 2012.
.png)
Isomalt Crystals,Factory Supply Isomalt,Healthcare Supplement Isomalt
Shandong Bailong Chuangyuan Bio-tech Co.,Ltd. Qingdao Branch , https://www.sdblcycn.com